| Literature DB >> 20652579 |
Abstract
In the last few decades, there is an increasing emergence and re-emergence of viruses, such as West Nile virus, Enterovirus 71 and henipaviruses that cause epidemic viral encephalitis and other central nervous system (CNS) manifestations. The mortality and morbidity associated with these outbreaks are significant and frequently severe. While aspects of epidemiology, basic virology, etc., may be known, the pathology and pathogenesis are often less so, partly due to a lack of interest among pathologists or because many of these infections are considered "third world" diseases. In the study of epidemic viral encephalitis, the pathologist's role in unravelling the pathology and pathogenesis is critical. The novel henipavirus infection is a good example. The newly created genus Henipavirus within the family Paramyxoviridae consists of two viruses, viz., Hendra virus and Nipah virus. These two viruses emerged in Australia and Asia, respectively, to cause severe encephalitides in humans and animals. Studies show that the pathological features of the acute encephalitis caused by henipaviruses are similar and a unique dual pathogenetic mechanism of vasculitis-induced microinfarction and parenchymal cell infection in the CNS (mainly neurons) and other organs causes severe tissue damage. Both viruses can cause relapsing encephalitis months and years after the acute infection due to a true recurrent infection as evidenced by the presence of virus in infected cells. Future emerging viral encephalitides will no doubt continue to pose considerable challenges to the neuropathologist, and as the West Nile virus outbreak demonstrates, even economically advanced nations are not spared.Entities:
Mesh:
Year: 2010 PMID: 20652579 PMCID: PMC7086526 DOI: 10.1007/s00401-010-0720-z
Source DB: PubMed Journal: Acta Neuropathol ISSN: 0001-6322 Impact factor: 17.088
Fig. 1Vascular and CNS pathology in acute henipavirus infection. a Cerebral vasculitis in acute Nipah virus encephalitis characterised by intramural inflammatory cells and necrosis and thrombo-occlusion of the lumen (arrow). b More subtle endotheliitis showing subendothelial infiltration of inflammatory cells (arrow) in acute Hendra virus encephalitis. c Immunolocalisation of Nipah viral antigens in endothelium (arrows). d Multinucleated giant cell (arrow) arising from the endothelium of a non-inflamed blood vessel in acute Nipah encephalitis. e Necrotic plaque in the cerebral cortex of acute Nipah encephalitis with adjacent thrombosed vessel (arrow). f White matter necrotic plaque in acute Hendra encephalitis that consists of eosinophilic, axonal spheroid-like material (arrow). H&E stains: a, b, d, e, h; immunoperoxidase stain using cross-reactive, anti-Hendra polyclonal antibodies with diaminobenzidine substrate and haematoxylin counterstain, c. Original magnifications: ×400 (a–d, f); ×40 (e)
Fig. 2CNS pathology in human henipavirus encephalitis. Cytoplasmic eosinophilic viral inclusions in a acute Nipah virus encephalitis (arrows), and b acute Hendra virus encephalitis (arrow). c Inclusion-like and granular Nipah viral antigens in neurons and neuropil. d Plaque-like, cluster of neurons immunostained for viral antigens in acute Hendra virus encephalitis. e Viral RNA within neurons in relapsing Nipah encephalitis. f Viral antigens within neurons in relapsing Hendra encephalitis. H&E stains, a, b; immunoperoxidase using cross reactive anti-Hendra polyclonal antibodies with diaminobenzidine substrate and haematoxylin counterstain, c, d, f; in situ hybridization using specific Nipah virus riboprobes with NBT/BCIP substrate and haematoxylin counterstain, e. Original magnifications: ×40 (d); ×400 (a–c, e, f)